Skip to content

MRI SOLUTION: what changed

BE 1001.475.609NACE 86.910, Medical imaging and medical laboratoriesOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€23,599
2024 · €29,816-€6,217
Equity
€58,054
2024 · €34,454+€23,599
Cash
€66,106
2024 · €32,178+€33,928
Balance sheet total
€77,631
2024 · €47,743+€29,888

Largest movements

2024 to 2025
Assets
  • Cash +€33,928

    up €33,928 (+105%), from €32,178 to €66,106

    mainly Net result for the year (+€23,599) and Depreciation (+€7,783)

  • Tangible fixed assets -€7,783

    down €7,783 (-50.0%), from €15,565 to €7,783

  • Receivables within one year +€3,133

    new in 2025: €3,133

Equity and liabilities
  • Profit (loss) carried forward +€23,599

    up €23,599 (+72.7%), from €32,454 to €56,054

  • Tax, wage and social debts +€6,689

    up €6,689 (+69.0%), from €9,699 to €16,387

  • Other debts -€969

    down €969 (-32.8%), from €2,954 to €1,985

Income statement
  • Gross operating margin -€7,975

    down €7,975 (-16.8%), from €47,539 to €39,564

  • Taxes -€1,448

    down €1,448 (-16.2%), from €8,918 to €7,470

  • Other operating charges -€494

    down €494 (-48.3%), from €1,022 to €528

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €29,816
Gross operating margin -€7,975
Other operating charges +€494
Financial income +€1
Financial charges -€185
Taxes +€1,448
Result 2025 €23,599
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€33,928
Investment €0
Financing €0
Cash 2024 €32,178
Net result for the year +€23,599
Depreciation +€7,783
Receivables within one year -€3,133
Deferred charges and accrued income -€610
Trade debts +€569
Tax, wage and social debts +€6,689
Other debts -€969
Cash 2025 €66,106
brings cash intakes cash out
Every line side by side 34 lines
Line Code 2024 2025 Change %
Total assets 20/58 €47,743 €77,631 +€29,888 +62.6%
Fixed assets 21/28 €15,565 €7,783 -€7,783 -50.0%
Tangible fixed assets 22/27 €15,565 €7,783 -€7,783 -50.0%
Furniture and vehicles 24 €15,565 €7,783 -€7,783 -50.0%
Current assets 29/58 €32,178 €69,849 +€37,671 +117%
Amounts receivable within one year 40/41 - €3,133 +€3,133
Trade receivables 40 - €3,133 +€3,133
Cash at bank and in hand 54/58 €32,178 €66,106 +€33,928 +105%
Deferred charges and accrued income 490/1 - €610 +€610
Total equity and liabilities 10/49 €47,743 €77,631 +€29,888 +62.6%
Equity 10/15 €34,454 €58,054 +€23,599 +68.5%
Contributions 10/11 €2,000 €2,000 = 0.0%
Profit (loss) carried forward 14 €32,454 €56,054 +€23,599 +72.7%
Amounts payable 17/49 €13,289 €19,578 +€6,289 +47.3%
Amounts payable within one year 42/48 €13,289 €19,578 +€6,289 +47.3%
Trade debts 44 €637 €1,206 +€569 +89.4%
Suppliers 440/4 €637 €1,206 +€569 +89.4%
Taxes, remuneration and social security 45 €9,699 €16,387 +€6,689 +69.0%
Taxes 450/3 €9,699 €16,387 +€6,689 +69.0%
Other amounts payable 47/48 €2,954 €1,985 -€969 -32.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €7,783 €7,783 = 0.0%
Other operating charges 640/8 €1,022 €528 -€494 -48.3%
Gross operating margin 9900 €47,539 €39,564 -€7,975 -16.8%
Operating profit (loss) 9901 €38,734 €31,253 -€7,481 -19.3%
Financial income 75/76B - €1 +€1
Recurring financial income 75 - €1 +€1
Non-recurring financial income 76B - €1 +€1
Financial charges 65/66B €0 €185 +€185 +123,367%
Recurring financial charges 65 €0 €185 +€185 +123,367%
Non-recurring financial charges 66B €0 €185 +€185 +123,367%
Profit (loss) for the period before taxes 9903 €38,734 €31,069 -€7,665 -19.8%
Income taxes 67/77 €8,918 €7,470 -€1,448 -16.2%
Profit (loss) for the period 9904 €29,816 €23,599 -€6,217 -20.9%
Profit (loss) for the period to be appropriated 9905 €29,816 €23,599 -€6,217 -20.9%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€95,977 to €122,757

Midpoint €107,135 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Adjusted equity €58,054
Capitalised earnings €133,900 to €187,460
Indication €95,977 to €122,757

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€58,054
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€58,054

Capitalised earnings

net result for the year (9904)
2025
€23,599
excluding non-recurring income and charges
€23,784
2024
€29,816
excluding non-recurring income and charges
€29,816
2023
€2,638
Average result, excluding non-recurring income and charges
€18,746
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€133,900 / €156,217 / €187,460

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 9 November 2026 via checked.be.